Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With LAP Protector
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01104233|
Recruitment Status : Unknown
Verified March 2010 by The First Affiliated Hospital of Guangzhou Medical University.
Recruitment status was: Recruiting
First Posted : April 15, 2010
Last Update Posted : April 15, 2010
|Condition or disease||Intervention/treatment|
|Lung Cancer||Device: LAP Protector|
|Study Type :||Observational|
|Estimated Enrollment :||80 participants|
|Official Title:||Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With Rigid Spreading Versus Soft Spreading (Using LAP Protector)|
|Study Start Date :||March 2010|
|Estimated Primary Completion Date :||October 2010|
|Estimated Study Completion Date :||December 2010|
The soft spreading
Patients with lung cancer underwent Video-assisted Thoracoscopic Surgery (VATS) with soft spreading (using LAP Protector).
Device: LAP Protector
The LAP Protector is a device that consists of two flexible rings made of superelasticity alloys covered with polyurethane polyamide, and a thin silicone rubber membrane that is attached to the outer rim of the two rings
The rigid spreading
Patients with lung cancer underwent Video-assisted Thoracoscopic Surgery (VATS) with rigid spreading.
- Compare the level of postoperative pain between the rigid and soft spreading groups [ Time Frame: 1 day ]The level of postoperative pain was measured by Visual Analogue Scale (VAS).
- Compare early postoperative analgesic requirements between the rigid and soft spreading groups [ Time Frame: 1 week ]Postoperative analgesic requirements (e.g. the amount of morphine titration).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01104233
|Contact: Xin Xu, MDfirstname.lastname@example.org|
|Contact: Wenlong Shao, MDemail@example.com|
|The First Affiliated Hospital of Guangzhou Medical College||Recruiting|
|Guangzhou, Guangdong, China, 510120|
|Contact: Weiqiang Yin, MD +86-20-83337792 firstname.lastname@example.org|
|Contact: Daoyuan Wang, MD +86-20-83337792 email@example.com|
|Principal Investigator: Jianxing He, MD, FACS|
|Principal Investigator:||Jianxing He, MD, FACS||The First Affiliated Hospital of Guangzhou Medical University|